Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: Retrospective analysis of 425 patients

International Journal of Radiation Oncology Biology Physics

Volumn 87, Issue 4, 2013, Pages 697-704

  Topkan, Erkan ^a   Parlak, Cem ^a   Selek, Ugur ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCURRENT CHEMORADIATION; METASTASES-FREE SURVIVALS; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; PLATINUM-BASED CHEMOTHERAPY; PROGRESSION FREE SURVIVAL; RETROSPECTIVE ANALYSIS;

BIOLOGICAL ORGANS; CHEMORADIOTHERAPY; DIAGNOSIS; PATIENT MONITORING;

DISEASES;

ANTIEMETIC AGENT; CISPLATIN; DOCETAXEL; NAVELBINE;

ACUTE RADIATION INDUCED ESOPHAGITIS; ADULT; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE ASSOCIATION; DISTANT METASTASIS FREE SURVIVAL; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LOCOREGIONAL PROGRESSION FREE SURVIVAL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TRACHEOESOPHAGEAL FISTULA; TREATMENT OUTCOME; VOMITING; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; BODY WEIGHT; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAXOIDS; VINBLASTINE; WEIGHT GAIN; WEIGHT LOSS;

EID: 84886095530     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.07.033     Document Type: Article

References (18)

1. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
2. W.J. Curran Jr., R. Paulus, and C.J. Langer Sequential vs concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 2011 1452 1460
3. A. Inui Cancer anorexia-cachexia syndrome: current issues in research and management CA Cancer J Clin 52 2002 72 91
4. M. Werner-Wasik, C. Scott, and J.D. Cox Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival Int J Radiat Oncol Biol Phys 48 2000 1475 1482
5. J.M. Argiles, M. Olivan, and S. Busquets Optimal management of cancer anorexia-cachexia syndrome Cancer Manag Res 2 2010 27 38
6. J.Y. Chang, and J.D. Cox Improving radiation conformality in the treatment of non-small cell lung cancer Semin Radiat Oncol 20 2010 171 177
7. E. Topkan, M.N. Yavuz, and C. Onal Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters Lung Cancer 63 2009 393 399
8. E. Jeffery, J. Sherriff, and C. Langdon A clinical audit of the nutritional status and need for nutrition support amongst head and neck cancer patients treated with radiotherapy Australas Med J 5 2012 8 13
9. H. Young, R. Baum, and U. Cremerius Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 35 1999 1773 1782
10. D.J. Sher, B.T. Gielda, and M.J. Liptay Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer Clin Lung Cancer 14 2013 370 375
11. B.H. Tan, and K.C. Fearon Cachexia: prevalence and impact in medicine Curr Opin Clin Nutr Metab Care 11 2008 400 407
12. P.J. Ross, S. Ashley, and A. Norton Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90 2004 1905 1911
13. B.T. Gielda, P. Mehta, and A. Khan Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival Int J Radiat Oncol Biol Phys 81 2011 985 991
14. A.J. Chang, and J.D. Bradley Clinical perspectives on dose escalation for non-small-cell lung cancer Clin Lung Cancer 11 2010 299 302
15. A. Laviano, M.M. Meguid, and A. Inui Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself Nat Clin Pract Oncol 2 2005 158 166
16. S.H. Jafri, R. Shi, and G. Mills Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review BMC Cancer 13 2013 158
17. H. Suzuki, A. Asakawa, and H. Amitani Cancer cachexia-pathophysiology and management J Gastroenterol 48 2013 574 594
18. D. Galetta, A. Rossi, and S. Pisconti Maintenance or non-maintenance therapy in the treatment of advanced non-small cell lung cancer: that is the question Cancer Treat Rev 36 Suppl. 3 2010 S30 S33